Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of NNC126-0083 in Adults with Growth Hormone Deficiency
NCT00715689Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2008
- Primary completion
- Mar 2009
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of somatropin pegol in growth hormone deficiency (GHD), sponsored by Novo Nordisk. Started Jul 2008; status: completed.
02
Drugs
somatropin pegol
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00715689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00715689.